Risk Analysis
Welcome.
Sign in or register.
Refer A Friend
|
Contact Us
Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
Tracking 1050 U.S. listed China Stocks and Counting...
Tracking 1535 U.S. Stocks and Counting...
Home
Market Activity
Shell Activity
Research
Message Boards
GeoBlog
About
GeoResearch
GeoBargains
GeoSpecials
Guidance
Make Goods
Penny Stocks
Recent Additions
All Companies
China Sky One Medical (PINK:CSKI)
GeoProfile
Overview
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders
Do you represent this company?
Learn how we can help increase your exposure to investors.
All
Research
Potential Valuation Scenarios
CFO Trail
Comments & Business Outlook
Financial Target Agreements
Financials
GeoBargain Notes
Investor Alert
Joint Venture
Liquidity Requirements
Shareholder Letters
Friday, May 30, 2008
Trailing EPS: $1.08
Forward EPS: $1.35
EPS future growth rate: 46%
EPS numbers have been adjusted to reflect a
fully taxed
scenario and any one time charges or gains. Future EPS numbers have been obtained from public sources. The GeoTeam feels that an adjustment to net income to reflect a
standard tax rate
is necessary for investors to make proper investment decisions.
Short Term (NOW) Scenarios Based on:
P/E of 25 on four quarters trailing EPS:
$27.00
P/E of 15 on four quarters forward EPS:
$28.05
Long Term (12 Months Forward) Scenario Based on:
P/E of 25 on four quarters forward EPS:
$46.75
Alternate Scenarios Based on P/E to EPS Growth Comparison:
Common rule of thumb that the P/E should equal the future EPS growth rate:
$49.68
These scenarios are not intended to be investment advice, but are scenarios based on some commonly used investment guidelines. They are provided to aid investors in making their own investment decisions
Permalink
Post a comment
Post Comment
Quick Facts
Industry
Pharma
Web site
cski.com.cn